Talke P, Caldwell J E, Richardson C A
Department of Anesthesia, University of California, San Francisco, 94143-0648, USA.
Anesthesiology. 1999 Jul;91(1):127-30. doi: 10.1097/00000542-199907000-00020.
The data on the effect of sevoflurane on intracranial pressure in humans are still limited and inconclusive. The authors hypothesized that sevoflurane would increase intracranial pressure as compared to propofoL METHODS: In 20 patients with no evidence of mass effect undergoing transsphenoidal hypophysectomy, anesthesia was induced with intravenous fentanyl and propofol and maintained with 70% nitrous oxide in oxygen and a continuous propofol infusion, 100 microg x kg(-1) x min(-1). The authors assigned patients to two groups randomized to receive only continued propofol infusion (n = 10) or sevoflurane (n = 10) for 20 min. During the 20-min study period, each patient in the sevoflurane group received, in random order, two concentrations (0.5 times the minimum alveolar concentration [MAC] and 1.0 MAC end-tidal) of sevoflurane for 10 min each. The authors continuously monitored lumbar cerebrospinal fluid (CSF) pressure, blood pressure, heart rate, and anesthetic concentrations.
Lumbar CSF pressure increased by 2+/-2 mmHg (mean+/-SD) with both 0.5 MAC and 1 MAC of sevoflurane. Cerebral perfusion pressure decreased by 11+/-5 mmHg with 0.5 MAC and by 15+/-4 mmHg with 1.0 MAC of sevoflurane. Systolic blood pressure decreased with both concentrations of sevoflurane. To maintain blood pressure within predetermined limits (within+/-20% of baseline value), phenylephrine was administered to 5 of 10 patients in the sevoflurane group (range = 50-300 microg) and no patients in the propofol group. Lumbar CSF pressure, cerebral perfusion pressure, and systolic blood pressure did not change in the propofol group.
Sevoflurane, at 0.5 and 1.0 MAC, increases lumbar CSF pressure. The changes produced by 1.0 MAC sevoflurane did not differ from those observed in a previous study with 1.0 MAC isoflurane or desflurane.
七氟醚对人体颅内压影响的数据仍然有限且尚无定论。作者推测,与丙泊酚相比,七氟醚会升高颅内压。方法:20例无占位效应证据的患者接受经蝶窦垂体切除术,静脉注射芬太尼和丙泊酚诱导麻醉,并用70%氧化亚氮和氧气以及100μg·kg⁻¹·min⁻¹的丙泊酚持续输注维持麻醉。作者将患者随机分为两组,一组仅持续输注丙泊酚(n = 10),另一组接受七氟醚(n = 10),持续20分钟。在20分钟的研究期间,七氟醚组的每位患者随机接受两种浓度(分别为0.5倍最低肺泡浓度[MAC]和1.0 MAC呼气末浓度)的七氟醚,每种浓度持续10分钟。作者持续监测腰段脑脊液(CSF)压力、血压、心率和麻醉浓度。
0.5 MAC和1 MAC的七氟醚均使腰段CSF压力升高2±2 mmHg(平均值±标准差)。0.5 MAC的七氟醚使脑灌注压降低11±5 mmHg,1.0 MAC的七氟醚使脑灌注压降低15±4 mmHg。两种浓度的七氟醚均使收缩压降低。为将血压维持在预定范围内(基线值的±20%以内),七氟醚组10例患者中有5例使用了去氧肾上腺素(剂量范围为50 - 300μg),丙泊酚组无患者使用。丙泊酚组的腰段CSF压力、脑灌注压和收缩压未发生变化。
0.5 MAC和1.0 MAC的七氟醚会升高腰段CSF压力。1.0 MAC七氟醚产生的变化与先前1.0 MAC异氟醚或地氟醚研究中观察到的变化无差异。